The Valley Desk

ArticleClinical lymphoma, myeloma & leukemiaPublished

Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Clinical lymphoma, myeloma & leukemia
Published
Subject terms
Humans; Antineoplastic Combined Chemotherapy Protocols; Retrospective Studies; Aged; Aged, 80 and over; Health Care Costs; Medicare; Patient Acceptance of Health Care; United States; Female; Male; Lymphoma, Large B-Cell, Diffuse
PubMed ID
38433043
Added to directory
Source checked

Report a correction or request removal